Skip to main content
Top

International Journal of Hematology

Issue 5/2011

Including PIH Articles on Memorial PIM: Adult T-cell Leukemia―from Discovery to Recent Progress

Content (16 Articles)

Special Feature

The discovery of ATL: an odyssey in restrospect

Junji Yodoi, Michiyuki Maeda

Progress in Hematology

Guest editorial: a new era of ATL and HTLV-1 research

Masao Matsuoka

Progress in Hematology

Current status of HTLV-1 infection

Toshiki Watanabe

Progress in Hematology

Molecular mechanisms of HTLV-1 infection and pathogenesis

Junichiro Yasunaga, Masao Matsuoka

Progress in Hematology

Antibody therapy for Adult T-cell leukemia–lymphoma

Takashi Ishida, Ryuzo Ueda

Review Article

The challenges of adherence and persistence with iron chelation therapy

John B. Porter, Michael Evangeli, Amal El-Beshlawy

Rapid Communication

Neurological syndrome after R-CHOP chemotherapy for a non-Hodgkin lymphoma: what is the diagnosis?

Dario Marino, Patrizia Farina, Antonio Jirillo, Giuseppe De Franchis, Marco Simonetto, Savina Maria Luciana Aversa

Original Article

Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia

Akio Shigematsu, Junji Tanaka, Ritsuro Suzuki, Yoshiko Atsuta, Takakazu Kawase, Yoichi M. Ito, Takuya Yamashita, Takahiro Fukuda, Keiki Kumano, Koji Iwato, Fumiaki Yoshiba, Heiwa Kanamori, Naoki Kobayashi, Takashi Fukuhara, Yasuo Morishima, Masahiro Imamura

Original Article

MK886 inhibits the proliferation of HL-60 leukemia cells by suppressing the expression of mPGES-1 and reducing prostaglandin E2 synthesis

YiQing Li, SongMei Yin, DaNian Nie, ShuangFeng Xie, LiPing Ma, XiuJu Wang, YuDan Wu, Jie Xiao

Case Report

Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection

Keisuke Kato, Yasuko Kojima, Chie Kobayashi, Kazumasa Mitsui, Ryoko Nakajima-Yamaguchi, Kazuko Kudo, Toshihiro Yanai, Ai Yoshimi, Tomohei Nakao, Tomohiro Morio, Mureo Kasahara, Kazutoshi Koike, Masahiro Tsuchida

Case Report

Glomerular hemophagocytic macrophages in a patient with proteinuria and clinical and laboratory features of hemophagocytic lymphohistiocytosis (HLH)

Ling Cao, William Dean Wallace, Shahrooz Eshaghian, Yuliya Linhares, Victor J. Marder

Case Report

A case of isolated thrombocytopenia due to cobalamin deficiency

Mesut Okur, Aybars Ozkan, Cemalettin Gunes, Murat Kaya, Kenan Kocabay

Case Report

Successful treatment of mast cell sarcoma of the uterus with imatinib

Hong Bing Ma, Xia Xu, Wei Ping Liu, Hong Chang, Fan Zeng, Yu Chun Wang

Case Report

Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder

Hiroaki Shimizu, Takayuki Saitoh, Hiroko Koya, Akinori Yuzuriha, Takumi Hoshino, Nahoko Hatsumi, Satoru Takada, Tomohito Nagaki, Yoshihisa Nojima, Toru Sakura

Letter to the Editor

Motor disability in the setting of oral anticoagulant therapy

Laura Scaramucci, Andrea Tendas, Pasquale Niscola, Francesco Bondanini, Marco Giovannini, Massimiliano Palombi, Luca Cupelli, Fabio Efficace, Alessio Perrotti, Paolo de Fabritiis

Letter to the Editor

Multi-focal EBV-mucocutaneous ulcer heralding late-onset T-cell immunodeficiency in a woman with lupus erythematosus

Wing Y. Au, Florence Loong, Thomas S. K. Wan, Antonio C. K. Tong

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine